NEW YORK (GenomeWeb) – After facing delays to commercialize its product as an in vitro diagnostic, life sciences firm InDevr aims to launch a research-use-only (RUO) version of its FluChip-8G Influenza A+B assay this year to help enhance influenza surveillance and pandemic preparation.

In the meantime, the firm is still pursuing US Food and Drug Administration Clearance, which it hopes to receive by 2019, and also plans to expand its resources to animal influenza surveillance.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.